Compare, Analyse Cadila Healthcare with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TEVA PHARMA (Israel) - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   TEVA PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
TEVA PHARMA
Dec-13
CADILA HEALTHCARE/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4323,190-   
Low Rs3062,771-   
Sales per share (Unadj.) Rs128.61,830.7-  
Earnings per share (Unadj.) Rs18.5114.4-  
Cash flow per share (Unadj.) Rs24.4262.3-  
Dividends per share (Unadj.) Rs3.50100.11-  
Dividend yield (eoy) %0.93.4 28.2%  
Book value per share (Unadj.) Rs101.52,033.5-  
Shares outstanding (eoy) m1,023.74848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.91.6 176.4%   
Avg P/E ratio x19.926.1 76.4%  
P/CF ratio (eoy) x15.111.4 133.3%  
Price / Book Value ratio x3.61.5 248.4%  
Dividend payout %18.987.5 21.6%   
Avg Mkt Cap Rs m378,1702,527,362 15.0%   
No. of employees `00012.444.9 27.7%   
Total wages/salary Rs m21,2410-   
Avg. sales/employee Rs Th10,585.034,539.9 30.6%   
Avg. wages/employee Rs Th1,707.80-   
Avg. net profit/employee Rs Th1,526.52,157.7 70.7%   
INCOME DATA
Net Sales Rs m131,6561,552,396 8.5%  
Other income Rs m2,0110-   
Total revenues Rs m133,6671,552,396 8.6%   
Gross profit Rs m29,731425,124 7.0%  
Depreciation Rs m5,986125,482 4.8%   
Interest Rs m1,93530,492 6.3%   
Profit before tax Rs m23,821269,151 8.9%   
Minority Interest Rs m4691,223 38.4%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-176,683 0.0%   
Tax Rs m5,303-3,286 -161.4%   
Profit after tax Rs m18,98796,977 19.6%  
Gross profit margin %22.627.4 82.5%  
Effective tax rate %22.3-1.2 -1,823.4%   
Net profit margin %14.46.2 230.9%  
BALANCE SHEET DATA
Current assets Rs m84,9811,048,482 8.1%   
Current liabilities Rs m73,425914,365 8.0%   
Net working cap to sales %8.88.6 101.6%  
Current ratio x1.21.1 100.9%  
Inventory Days Days7591 82.1%  
Debtors Days Days11096 114.2%  
Net fixed assets Rs m133,493507,047 26.3%   
Share capital Rs m1,0243,821 26.8%   
"Free" reserves Rs m102,8390-   
Net worth Rs m103,8631,724,417 6.0%   
Long term debt Rs m39,497793,775 5.0%   
Total assets Rs m234,8313,547,722 6.6%  
Interest coverage x13.39.8 135.4%   
Debt to equity ratio x0.40.5 82.6%  
Sales to assets ratio x0.60.4 128.1%   
Return on assets %8.93.6 248.0%  
Return on equity %18.35.6 325.1%  
Return on capital %18.34.9 371.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m36,8110-   
CASH FLOW
From Operations Rs m28,823247,372 11.7%  
From Investments Rs m-57,387-87,654 65.5%  
From Financial Activity Rs m18,846-296,739 -6.4%  
Net Cashflow Rs m-7,105-137,021 5.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 76.42 Rs / USD

Compare CADILA HEALTHCARE With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare CADILA HEALTHCARE With: ALKEM LABORATORIES  TTK HEALTHCARE  PFIZER  WOCKHARDT  CIPLA  



Today's Market

Indian Indices End Lower, Manufacturing Activity Amid Lockdown, and Top Cues in Focus Today(Pre-Open)

Indian share markets witnessed selling pressure and ended lower on Friday. Selling came as market participants were worried about the economic impact.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

One Stock that is All Charged Up for the Post Coronavirus Rebound (The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak (Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

CADILA HEALTHCARE SHARE PRICE


Apr 3, 2020 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - STRIDES PHARMA SCIENCE COMPARISON

COMPARE CADILA HEALTHCARE WITH

OTHER USEFUL LINKS

MARKET STATS